AI Clinical Notes: What Clinicians Actually Need to Know in 2026

Two-thirds of U.S. physicians now use some form of AI in their practice, up from 38% just three years ago. The fastest-growing use case is documentation. AI clinical notes, generated by ambient listening tools or structured note assistants, have moved from pilot programs to default features inside major EHR platforms. But adoption has outpaced the hard conversations about accuracy, consent, and data retention. This piece covers what's real, what's risky, and what questions to ask before you sign a contract or click "accept."

Key Takeaways

• Clinical AI notes are now a mainstream EHR feature, not a specialty add-on, with roughly a third of providers already having access to ambient scribe tools as of early 2026.
• Accuracy is stable but not perfect: large-scale studies show ~89% semantic agreement between AI-generated and clinician-reviewed notes, which means roughly one in ten elements needs correction.
• The biggest legal risk is not hallucination but consent. A 2026 class-action lawsuit alleges patient audio was transmitted to external systems without meaningful informed consent.
• Federal regulation is trending toward less mandatory AI transparency in certified EHRs, not more, which shifts the burden of vetting tools onto buyers.
• The questions that matter most during procurement are about data retention windows, audio deletion timelines, and whether transcripts are used to train models.

What Are AI Clinical Notes, Exactly?

AI clinical notes are medical documentation generated or drafted by software rather than typed from scratch by a clinician. The term covers a range of tools. Some listen to patient encounters through a microphone (ambient AI scribes) and produce a structured SOAP note after the visit. Others take dictated or typed fragments and expand them into complete notes. A few work inside EHR systems to pull data from the chart and pre-fill sections.

The underlying technology is a large language model, a type of AI trained on massive text corpora, applied to the specific domain of medical documentation. What makes these tools clinical rather than generic is the formatting (SOAP, H&P, progress notes), the medical vocabulary, and the integration with electronic health records.

The term "clinical AI notes" refers to the same category. Some people search for it in that word order. Same tools, same risks, same considerations.

How Widely Are AI Clinical Notes Actually Used?

More widely than most people assume. As of January 2026, roughly one-third of healthcare providers had access to ambient AI scribe technology, and adoption was accelerating. The U.S. Department of Veterans Affairs expanded its ambient AI scribe deployment to all VA medical centers nationwide throughout 2026, making it the largest government healthcare AI deployment in the country.

EHR vendors have embedded ambient documentation directly into their core platforms. In early 2026, one major vendor launched a built-in ambient documentation feature, and another announced a competing tool bundled into its mobile app at no extra cost. The signal is clear: ambient notes are becoming a default EHR feature rather than a third-party integration.

The market reflects this. One estimate puts the AI medical scribe software market at $1.53 billion in 2025, growing to $1.94 billion in 2026. Another projects the global ambient AI scribe market reaching roughly $13.8 billion by 2034. The numbers vary, but the direction is unanimous.

How Accurate Are AI-Generated Clinical Notes?

Accurate enough to be useful, not accurate enough to skip review. A large-scale study spanning 16 months and millions of encounters found semantic agreement between AI-generated and clinician-reviewed notes held stable at 87.4 to 89.2 percent, with a global weighted accuracy of 89.32%. That stability is notable. It means quality did not erode as usage scaled.

But 89% is not 100%. Roughly one in ten semantic elements needs correction. In a note with 20 discrete clinical assertions, that could mean two items are wrong, missing, or misleading. Some errors are trivial (a synonym substitution, a reordered list). Others are dangerous (a missed medication, a wrong dosage, an omitted allergy).

The practical takeaway: every AI-generated note requires clinician review before signing. The tool drafts. You finalize. Treat it like a first-year resident's note, not a finished document.

A separate point often conflated with accuracy: a large NEJM analysis described time savings from AI documentation as "modest". The tools help, but the magnitude of time saved is smaller than marketing materials suggest, especially once you account for the review step.

What Is the Biggest Legal Risk With AI Clinical Notes?

Consent. Not accuracy. Not hallucination. Consent.

In April 2026, a putative class-action was filed in the Northern District of California against Sutter Health, Memorial Health Services, and MemorialCare. The allegation: an ambient AI documentation tool recorded confidential patient conversations and transmitted audio to external systems without meaningful, informed consent. The plaintiffs argue consent should have been obtained before recording began, not buried in intake paperwork or mentioned in passing.

This is the first major test case. It may define how courts view ambient clinical AI for years. The core question is not whether the technology works but whether patients understood what was happening to their words.

For clinicians and practice managers, this means the consent workflow matters as much as the tool itself. A verbal mention at the start of a visit is probably not sufficient. A checkbox on a tablet in the waiting room might not be either, depending on jurisdiction. The safest approach is explicit, documented, pre-encounter consent that specifically names ambient recording and external processing.

Does HIPAA Cover AI Scribe Consent?

Not as cleanly as you would expect. HIPAA governs how protected health information is used and disclosed, and a Business Associate Agreement (BAA) between the provider and the AI vendor is a baseline requirement. But HIPAA does not specifically address whether a patient must consent to being recorded by an ambient AI tool during a clinical encounter. State wiretapping and eavesdropping laws fill some of that gap, and they vary dramatically. California, where the Sutter lawsuit was filed, is a two-party consent state for recordings. Other states are one-party. The patchwork creates real exposure for multi-state health systems.

How Is Regulation Trending?

Toward less mandatory transparency, not more. That may surprise you.

In 2025, the U.S. Office of the National Coordinator for Health IT (ONC) built AI transparency requirements into certified EHR systems. A subsequent 2025 proposal aimed to strip those requirements back out. If finalized, the federal mandate for AI transparency in certified EHRs would weaken, pushing the burden of vetting embedded AI back onto provider organizations and the market itself.

Canada has moved faster on the regulatory side. British Columbia's privacy commissioner released guidance in January 2026 for healthcare organizations adopting AI scribe tools, and Ontario's privacy commissioner issued a similar document the same month.

The practical implication for U.S. buyers: you cannot rely on certification requirements to ensure your AI documentation vendor handles data responsibly. You have to ask the hard questions yourself.

What Questions Should You Ask an AI Scribe Vendor?

Data retention and training-data use are the real differentiators now that basic HIPAA compliance is table stakes. Vendor practices differ substantially in how long audio and transcripts are retained and whether that data is used for AI model training. Here are the questions that matter:

• Audio deletion timeline. When is the raw audio recording deleted? Some vendors delete within minutes. Others retain it for days or weeks. A few keep it indefinitely unless you opt out.
• Transcript retention. The generated text may persist longer than the audio. Ask how long transcripts are stored outside your EHR, and in what form.
• Training-data use. Is any patient data, audio, transcript, or note content used to train or fine-tune the vendor's models? If yes, is it anonymized first, and how? "De-identified" is not the same as "not used."
• Processing location. Where does the audio get transcribed and the note get generated? On-device, in a U.S. data center, or offshore? Data residency matters for state-level privacy laws and for patient trust.
• Subprocessor chain. Does the vendor use third-party AI providers for inference? If so, what are their retention and training policies? A BAA with the vendor does not automatically extend to the vendor's vendor.

If a vendor cannot answer these questions clearly, that is itself an answer.

Who Gets Left Out by AI Clinical Notes?

Equity gaps in AI documentation tools are real and documented. Feedback submitted to the U.S. government in early 2026 flagged that AI scribes work poorly in languages other than English. For clinics serving immigrant communities, this is not a minor inconvenience. It is a fundamental gap that could lead to inaccurate notes, missed clinical details, and worse outcomes.

Pediatric and geriatric patients are also underserved. These groups are underrepresented in training data, which means the models are less reliable when documenting encounters with children or elderly patients. A tool trained primarily on adult primary care visits will miss the linguistic patterns and clinical nuances of a pediatric neurology consult or a geriatric palliative care conversation.

If your patient population includes non-English speakers, children, or elderly patients, test the tool specifically on those encounters before committing. Do not extrapolate from demos run on adult English-speaking primary care visits.

How Should a Practice Implement AI Clinical Notes?

Start small, measure what matters, and build the consent workflow before you buy the software.

Step one: fix consent first. Design your informed consent process for ambient recording. Make it explicit, documented, and pre-encounter. Train front-desk staff and clinicians on the script. This is cheaper than a lawsuit.

Step two: pilot with a narrow scope. Pick one department or one visit type. Run the AI tool in parallel with existing documentation for at least two weeks. Have clinicians review every generated note and track the types and frequency of errors.

Step three: measure the right things. Time saved per note is the obvious metric, but it is not the most important one. Track error rate by category (omission, commission, hallucination). Track patient complaints or concerns about recording. Track clinician satisfaction, because if the review burden offsets the drafting benefit, net value is zero.

Step four: establish a review policy. A JAMIA survey of health-system leaders found that accuracy concerns and unresolved liability questions are the top barriers to broader AI documentation use. If an AI tool contributes to a harmful mistake, the question of who is legally responsible remains open. Until case law clarifies this, the safest posture is clear: the signing clinician owns the note. Full stop. Review is not optional.

Step five: negotiate retention terms in your contract. Do not accept default data retention policies. Negotiate audio deletion timelines, transcript storage limits, and explicit prohibitions on training-data use. Get these in the BAA, not just in marketing materials.

Are AI Clinical Notes Worth It?

For most practices, yes, with caveats. The documentation burden in medicine is severe. Clinicians spend roughly two hours on documentation for every hour of direct patient care. Any tool that reduces that ratio, even modestly, has value. AI-drafted notes do reduce the blank-page problem. Starting from a structured draft is faster than starting from nothing, even if the draft needs correction.

The caveats are real. Time savings are modest, not dramatic. Review is mandatory. Consent workflows add friction. Equity gaps exclude some patient populations. Litigation risk is emerging. And the regulatory environment is, if anything, becoming less protective, not more.

The clinicians who benefit most are those who document high volumes of similar visit types: primary care, urgent care, straightforward follow-ups. The tool handles the template; the clinician handles the judgment. Complex, multi-problem encounters with nuanced clinical reasoning still require heavy editing, and the time savings shrink accordingly.

What Does Privacy-First AI Documentation Look Like?

The current generation of ambient AI scribes transmits audio to external servers for processing. That is the architectural norm. The audio leaves the exam room, travels to a cloud endpoint, gets transcribed by one model, structured by another, and the resulting note gets sent back to the EHR. Multiple systems touch the data along the way.

A privacy-first approach would minimize the surface area at each step. Short retention windows for audio and transcripts, measured in minutes rather than days. No use of patient data for model training. Clear subprocessor disclosure so buyers know every entity that touches the data. Explicit, granular consent obtained before the microphone turns on.

These are not hypothetical criteria. They are the questions Canadian privacy commissioners are already asking providers to answer. Ontario and British Columbia both issued guidance documents in January 2026 that amount to a practical checklist for evaluating AI scribe privacy practices. U.S. providers would do well to adopt the same framework, because the U.S. regulatory environment is less prescriptive, not because the risks are smaller.

How Does This Connect to AI Beyond Clinical Documentation?

Clinical documentation is one slice of a broader shift toward AI that handles sensitive personal information. The same questions apply anywhere AI processes private data: who controls the data, how long it persists, who can read it, and whether the person whose data it is understood and agreed to what would happen.

At Selina, we build an AI assistant designed around those questions from the start. Memory is adaptive and encrypted at rest, not a raw transcript of everything you have said. Files sent through SelinaSEND use zero-knowledge encryption. Conversations are encrypted in transit and at rest. We run on a stack of frontier models, routed per task, via API. We are not a clinical documentation tool, and we do not make clinical claims. But the architecture reflects the same principle: the person whose data it is should control what happens to it.

If you work with sensitive information of any kind and want an AI assistant that treats privacy as a structural constraint rather than a policy checkbox, start a free 7-day trial, no card required.

Michael C.

Founder & Principal Engineer, Selina Labs

Michael builds Selina, a privacy-first AI that remembers you across conversations. He ships security-sensitive AI in production — real attacks, real fixes, measured in minutes and dollars — and writes about privacy, security, and LLMs from that seat. Top Rated Plus and expert-verified on Upwork.

• www.upwork.com
• x.com
• medium.com
• selinalabs.io